Tuesday, August 30, 2022 1:58:36 PM
Gabapentin and "SOHM, Inc., has signed agreements with various ANDA holders to license products under the SOHM private label for distribution in the United States. New products include Colsevelam Hydrochloride, used to lower high cholesterol levels in the blood. Topiramate, an anticonvulsant drug used in the control of epilepsy and in the prophylaxis and treatment of migraines, and Salsalate, is used to help treat the pain of osteoarthritis or rheumatoid arthritis. The company expects the revenues of newly added products to begin Q4 of 2022"
So do you believe SOHM Inc is going to just hold on to these products orDISTRIBUTE THEIR PRIVATE LABEL PRODUCTS directly to pharmacies and other distributors to sell to pharmacies?
Recent SHMN News
- Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor • AllPennyStocks.com • 06/10/2024 06:30:00 PM
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM